142 related articles for article (PubMed ID: 18445226)
1. 13-cis-retinoic acid alters the cellular morphology of slice-cultured serotonergic neurons in the rat.
Ishikawa J; Sutoh C; Ishikawa A; Kagechika H; Hirano H; Nakamura S
Eur J Neurosci; 2008 May; 27(9):2363-72. PubMed ID: 18445226
[TBL] [Abstract][Full Text] [Related]
2. Effects of retinoic acids on the dendritic morphology of cultured hippocampal neurons.
Liu Y; Kagechika H; Ishikawa J; Hirano H; Matsukuma S; Tanaka K; Nakamura S
J Neurochem; 2008 Aug; 106(3):1104-16. PubMed ID: 18466335
[TBL] [Abstract][Full Text] [Related]
3. 13-cis-Retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro.
O'Reilly KC; Trent S; Bailey SJ; Lane MA
Exp Biol Med (Maywood); 2007 Oct; 232(9):1195-203. PubMed ID: 17895527
[TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid.
Cisneros FJ; Gough BJ; Patton RE; Ferguson SA
J Appl Toxicol; 2005; 25(6):470-8. PubMed ID: 16092084
[TBL] [Abstract][Full Text] [Related]
6. Oral treatment with retinoic acid decreases bone mass in rats.
Hotchkiss CE; Latendresse J; Ferguson SA
Comp Med; 2006 Dec; 56(6):502-11. PubMed ID: 17219781
[TBL] [Abstract][Full Text] [Related]
7. 13-Cis-retinoic acid decreases hypothalamic cell number in vitro.
Griffin JN; Pinali D; Olds K; Lu N; Appleby L; Doan L; Lane MA
Neurosci Res; 2010 Nov; 68(3):185-90. PubMed ID: 20708044
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling.
Katsuki H; Kurimoto E; Takemori S; Kurauchi Y; Hisatsune A; Isohama Y; Izumi Y; Kume T; Shudo K; Akaike A
J Neurochem; 2009 Jul; 110(2):707-18. PubMed ID: 19457078
[TBL] [Abstract][Full Text] [Related]
9. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
10. Regulation of alpha 2(I) collagen expression in stellate cells by retinoic acid and retinoid X receptors through interactions with their cofactors.
Wang L; Tankersley LR; Tang M; Potter JJ; Mezey E
Arch Biochem Biophys; 2004 Aug; 428(1):92-8. PubMed ID: 15234273
[TBL] [Abstract][Full Text] [Related]
11. Running increases neurogenesis without retinoic acid receptor activation in the adult mouse dentate gyrus.
Aberg E; Perlmann T; Olson L; Brené S
Hippocampus; 2008; 18(8):785-92. PubMed ID: 18493951
[TBL] [Abstract][Full Text] [Related]
12. Retinoid receptors involved in the effects of retinoic acid on rat testis development.
Livera G; Rouiller-Fabre V; Habert R
Biol Reprod; 2001 May; 64(5):1307-14. PubMed ID: 11319133
[TBL] [Abstract][Full Text] [Related]
13. 13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice.
Sakai Y; Crandall JE; Brodsky J; McCaffery P
Ann N Y Acad Sci; 2004 Jun; 1021():436-40. PubMed ID: 15251924
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
[TBL] [Abstract][Full Text] [Related]
15. Oral Accutane (13-cis-retinoic acid) has no effects on spatial learning and memory in male and female Sprague-Dawley rats.
Ferguson SA; Berry KJ
Neurotoxicol Teratol; 2007; 29(2):219-27. PubMed ID: 17161936
[TBL] [Abstract][Full Text] [Related]
16. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
Sakuta T; Kanayama T
Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
[TBL] [Abstract][Full Text] [Related]
17. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
[TBL] [Abstract][Full Text] [Related]
18. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats.
Ferguson SA; Cisneros FJ; Gough B; Hanig JP; Berry KJ
Toxicol Sci; 2005 Oct; 87(2):451-9. PubMed ID: 16033993
[TBL] [Abstract][Full Text] [Related]
19. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H
J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523
[TBL] [Abstract][Full Text] [Related]
20. Effects of inflammatory cytokines IL-1beta, IL-6, and TNFalpha on the intracellular localization of retinoid receptors in Schwann cells.
Mey J; Schrage K; Wessels I; Vollpracht-Crijns I
Glia; 2007 Jan; 55(2):152-64. PubMed ID: 17078027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
